Shire to highlight new research into chronic hypoparathyroidism at ECE
Shire announced new research to be presented on rhPTH(1-84) and on the treatment and management of chronic hypoparathyroidism at the upcoming 19th Annual Meeting of the European Congress of Endocrinology, 20-23 May, Lisbon, Portugal. The data being shared provides valuable new insights into chronic hypoparathyroidism, including the long term treatment effect of rhPTH(1-84), extensive global registry data on a number of disease related variables, and patient-reported outcome data on symptoms related to the disease from the Hypoparathyroidism Symptom Diary. These data demonstrate Shire's long term commitment to improving our understanding of this rare condition in order to further improve the lives of people living with chronic hypoparathyroidism. At the congress, there will be three poster presentations on chronic hypoparathyroidism and two satellite symposia.